Metraipolis › archive › dc_d261b052eb6f

Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41122986
DOI
10.1111/ejh.70026
License (as archived)
solo-consultazione
Archived
2026-11-09T03:48:26.368Z
SHA-256 of the archived text
4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07
Stable URL of this page
https://metraipolis.com/documento/dc_d261b052eb6f

How to cite

Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986 — Europe PMC (en), https://europepmc.org/article/MED/41122986 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d261b052eb6f (Metraipolis archive dc_d261b052eb6f, sha256 4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07)
BibTeX
@misc{dcd261b052eb6f,
  title = {Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41122986},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d261b052eb6f; sha256 4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122986. Agents can read the archived copy with the MCP tool read_document.